Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates
Authors
Keywords
antibody drug conjugates, PKPD modeling, Drug-Antibody-Ratio (DAR), site specific conjugation, tumor growth
Journal
PHARMACEUTICAL RESEARCH
Volume 32, Issue 6, Pages 1884-1893
Publisher
Springer Nature
Online
2014-12-03
DOI
10.1007/s11095-014-1582-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Trastuzumab Emtansine: First Global Approval
- (2013) Anita Ballantyne et al. DRUGS
- Methods for site-specific drug conjugation to antibodies
- (2013) Christopher R Behrens et al. mAbs
- Semi-mechanistic Population Pharmacokinetic Model of Multivalent Trastuzumab Emtansine in Patients with Metastatic Breast Cancer
- (2012) V L Chudasama et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Bench to bedside translation of antibody drug conjugates using a multiscale mechanistic PK/PD model: a case study with brentuximab-vedotin
- (2012) Dhaval K. Shah et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Pharmacokinetic Considerations for Antibody Drug Conjugates
- (2012) Kedan Lin et al. PHARMACEUTICAL RESEARCH
- Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry
- (2011) Keyang Xu et al. ANALYTICAL BIOCHEMISTRY
- Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats
- (2011) C. Andrew Boswell et al. BIOCONJUGATE CHEMISTRY
- Potent antibody drug conjugates for cancer therapy
- (2009) Peter D Senter CURRENT OPINION IN CHEMICAL BIOLOGY
- Modeling of tumor growth and anticancer effects of combination therapy
- (2009) Gilbert Koch et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
- (2008) Stephen C. Alley et al. BIOCONJUGATE CHEMISTRY
- Antibody-Drug Conjugates for Cancer Therapy
- (2008) Paul J. Carter et al. CANCER JOURNAL
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs
- (2008) Jagath R. Junutula et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started